Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years

Background Increased sympathetic activity may be an underlying mechanism in cardiovascular disease. It has been hypothesized that the degree of left ventricular (LV) hypertrophy is partly related to the blood pressure level, and partly to neurohormonal factors. The aim of this study was to investigate predictors of LV mass, including arterial plasma noradrenaline as an index of sympathetic activity, with particular emphasis on subjects who developed hypertension over a period of 20 years. Methods In a 20-year prospective study of middle-aged men, sustained hypertensives (n = 22), new hypertensives (crossovers) (n = 17) and sustained normotensives (controls) (n = 17) were examined both at baseline and after 20 years of follow-up (at ages 42.1 ± 0.5 and 62.3 ± 0.6 years, respectively). Relationships between arterial plasma catecholamines, blood pressure and body mass index at baseline to left ventricular parameters by echocardiography at follow-up were investigated. Results Groups were homogeneous regarding age, gender, race and body build. The group of sustained hypertensives had significantly more LV hypertrophy (P = 0.025) and diastolic dysfunction (P = 0.010). Among the crossovers, LV mass index was positively correlated to arterial plasma noradrenaline (r = 0.50, P = 0.043) and body mass index (BMI) (r = 0.51, P = 0.039) and showed a positive trend with systolic blood pressure (SBP) at baseline. Arterial plasma noradrenaline (β = 0.47) was found to predict LV mass index after 20 years independently of BMI (β = 0.45) and SBP (β = 0.22) at baseline (R2 adjusted = 0.345, P = 0.037). Such a relationship was not found in the controls or in the sustained hypertensives, of which 16 were treated with antihypertensive drugs. Conclusions Arterial plasma noradrenaline at baseline, as an index of sympathetic activity, predicts LV mass at follow-up independently of systolic blood pressure and body build in middle-aged men who developed hypertension over a period of 20 years.

[1]  Beretta-Piccoli,et al.  Plasma Catecholamines and Essential Hypertension An Analytical Review , 2005 .

[2]  A. Tannapfel,et al.  Norepinephrine-Induced Changes in Cardiac Transforming Growth Factor-&bgr; Isoform Expression Pattern of Female and Male Rats , 2004, Hypertension.

[3]  S. Oparil,et al.  Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study , 2004, Journal of Human Hypertension.

[4]  M. Esler,et al.  Sympathetic Augmentation in Hypertension: Role of Nerve Firing, Norepinephrine Reuptake, and Angiotensin Neuromodulation , 2004, Hypertension.

[5]  M. Nieminen,et al.  Losartan benefits over atenolol in non‐smoking hypertensive patients with left ventricular hypertrophy: The LIFE study , 2004, Blood pressure.

[6]  K. Bailey,et al.  Association of newer diastolic function parameters with age in healthy subjects: a population-based study. , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[7]  M. Esler,et al.  Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy , 2003, Circulation.

[8]  F. Rossi,et al.  Aldosterone induces contraction of the resistance arteries in man. , 2003, Atherosclerosis.

[9]  A. Struthers Aldosterone: cardiovascular assault. , 2002, American heart journal.

[10]  H. Dige-Petersen,et al.  Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension. , 2002, American heart journal.

[11]  J. Greenwood,et al.  Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive. , 2001, Journal of the American College of Cardiology.

[12]  A. Pessina,et al.  The Endothelin‐Aldosterone Axis and Cardiovascular Diseases , 2001, Journal of cardiovascular pharmacology.

[13]  S. Kjeldsen,et al.  Supine and exercise systolic blood pressure predict cardiovascular death in middle-aged men , 2001, Journal of hypertension.

[14]  H. Baba,et al.  Cardiac remodeling after long term norepinephrine treatment in rats. , 2001, Cardiovascular research.

[15]  G. Mancia,et al.  Adrenergic and Reflex Abnormalities in Obesity-Related Hypertension , 2000, Hypertension.

[16]  M. Nieminen,et al.  Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study) , 2000 .

[17]  D. Levy,et al.  Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. , 1998, Journal of the American College of Cardiology.

[18]  S. Glasser Hypertension, hypertrophy, hormones, and the heart. , 1998, American heart journal.

[19]  J. Seward,et al.  The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. , 1997, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[20]  L. Hatle,et al.  Doppler evaluation of left and right ventricular diastolic function: a technical guide for obtaining optimal flow velocity recordings. , 1997, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[21]  B. Strauer,et al.  Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients , 1996, Journal of hypertension.

[22]  J. Schwartz,et al.  Association of carotid atherosclerosis and left ventricular hypertrophy. , 1995, Journal of the American College of Cardiology.

[23]  N. Schork,et al.  Sex‐Specific Determinants of Increased Left Ventricular Mass in the Tecumseh Blood Pressure Study , 1994, Circulation.

[24]  H. Bjørnstad,et al.  Left Ventricular Mass and Cardiovascular Reactivity in Young Men , 1994, Hypertension.

[25]  S. Kjeldsen,et al.  Cardiovascular reactivity, coronary risk factors, and sympathetic activity in young men. , 1993, Hypertension.

[26]  K Rodahl,et al.  Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men. , 1993, The New England journal of medicine.

[27]  K. Weber,et al.  Cardioreparation and the concept of modulating cardiovascular structure and function. , 1993, Blood pressure.

[28]  J. Stewart,et al.  Altered Function and Structure of the Heart in Dogs With Chronic Elevation in Plasma Norepinephrine , 1991, Circulation.

[29]  D E Manyari,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[30]  N. Schork,et al.  Arterial plasma norepinephrine correlates to blood pressure in middle-aged men with sustained essential hypertension. , 1989, American heart journal.

[31]  A. Tajik,et al.  Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography. Part II. Clinical studies. , 1989, Mayo Clinic proceedings.

[32]  D. Levy,et al.  Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. , 1989, Annals of internal medicine.

[33]  I. Hjermann,et al.  Decreased central dopaminergic activity in essential hypertension. , 1987, Journal of hypertension.

[34]  I. Hjermann,et al.  Aging and urinary vasopressin excretion in healthy men. , 1987, Scandinavian journal of urology and nephrology.

[35]  I. Hjermann,et al.  Endocrine and haemodynamic responses to graded dopamine infusion in essential hypertension. , 1987, Scandinavian journal of clinical and laboratory investigation.

[36]  J. Laragh,et al.  Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. , 1986, Annals of internal medicine.

[37]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[38]  I. Hjermann,et al.  Evidence of age-related variation in plasma vasopressin of normotensive men. , 1985, Scandinavian journal of clinical and laboratory investigation.

[39]  F. Dunn,et al.  Clinical and hemodynamic determinants of left ventricular dimensions. , 1984, Archives of internal medicine.

[40]  S. Kjeldsen,et al.  Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension. , 1982, Scandinavian journal of clinical and laboratory investigation.

[41]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[42]  J. Peuler,et al.  Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. , 1977, Life sciences.